EGFR and BIRC5 (survivin) mRNA expression levels were assessed based on breast cancer intrinsic subtype using our PDX RNA-sequencing data, as well as RNA-sequencing data from two different breast cancer cell line gene expression databases: the Harvard Medical School (HMS) Library of Integrated Network-based Cellular Signatures (LINCS) Breast Cancer Profiling Project (http://lincs.hms.harvard.edu/db/datasets/20348/) and the Broad Institute Cancer Cell Line Encyclopedia (CCLE) (https://portals.broadinstitute.org/ccle). The gene discussed is EGFR; the disease is cancer.